Firategrast (SB-683699) is an experimental drug which is an orally active and selective antagonist of the α4β1 and α4β7 integrin receptors. It reduces trafficking of lymphocytes into the central nervous system, and is in clinical trials for the treatment of multiple sclerosis.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.